Cell name:
MCF-7(orthotopic)
Other names for the model:
MCF 7、MCF.7、MCF7、Michigan Cancer Foundation-7、ssMCF-7、ssMCF7、MCF7/WT、MCF7-CTRL、IBMF-7
Cell information:
MCF-7 cells are derived from human breast cancer pleural effusion and are ER+, PR+, HER2+/-, and EGFR+ breast cancer cells. Click to viewMore information.
Model information:
Breast pad orthotopic inoculation, mouse strain NOD/SCID, requires long-term estrogen tablets, and matrix needs to be added during inoculation. Approximately 9 days after vaccination can be grouped, and the administration time after grouping is approximately 28 days. (Information on estrogen tablets: E2 Mouse-90d estrogen sustained-release tablets)Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059